Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  Type 1 DiabetesChildren & TeensInfectious DiseaseIssue 701

Type of Enterovirus Linked to Type 1 Diabetes

Researchers have homed in on the group B coxsackie viruses....

Advertisement

Although there has been a considerable amount of research describing the link between type 1 diabetes and enterovirus, which is comprised of more than 100 types including the virus responsible for polio, it was not until recently that researchers from two independent studies determined the specific type of enterovirus that can attack the insulin-producing cells in the pancreas and lead to type 1 diabetes.

Enteroviruses can infect anyone; however, they are more common among infants, children and teenagers because of their lack of immunity. One of the two studies that identified the specific type of enterovirus responsible for causing type 1 diabetes involved children at genetic risk from birth until age 15 or diagnosis of the disease. This study was known as the Finnish Type 1 Diabetes Prediction and Prevention (DIPP) study. The other study, known as the VirDiab study, involved children with newly diagnosed diabetes. Both studies identified that the group B coxsackie viruses were associated with the risk of developing type 1 diabetes; whereas no association with the other 35 types was observed. The group B coxsackie viruses include six enteroviruses.

Researchers said that a vaccine against the virus, similar to a polio vaccine, might be an option eventually in preventing or delaying the onset of type 1 diabetes.

Diabetes, October 2013
 
Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 01 November, 2013 and appeared in  Type 1 DiabetesChildren & TeensInfectious DiseaseIssue 701

Past five issues: Issue 796 | Diabetes Clinical Mastery Series Issue 255 | Issue 795 | SGLT-2 Inhibitors Special Edition August 2015 | Diabetes Clinical Mastery Series Issue 254 |

2015 Most Popular Articles:

Coffee Consumption Proves Potential in Reducing Type 2 Diabetes Risk
Posted August 07, 2015
Impaired Glucose Uptake in the Brain May Increase Alzheimer's Disease Risk
Posted August 07, 2015
First Non-Surgical Weight Loss Procedure for Mild-to-Moderate Obesity
Posted August 07, 2015
GLP-1 Agonist Semaglutide Completes Phase III Trial with Positive Results
Posted August 07, 2015
Two New Possible Methods for Diagnosing and Monitoring Diabetes
Posted August 07, 2015
Impact of Switching Insulin Glargine to Insulin Detemir in T2 Patients
Posted August 14, 2015
SIgnificant Weight Gain Associated with Laparoscopic Sleeve Gastrectomy
Posted August 14, 2015
Diabetes Combination Drug LixiLan Meets Main Target in Late Stage Trial
Posted August 07, 2015
Ketoacidosis Not as Great as Thought in Diabetes Patients Taking Invokana
Posted August 13, 2015
A Telltale Sign of Type 2 Diabetes
Posted August 07, 2015


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
What percentage of your patients have reached goal for A1c, BP and cholesterol?

CME/CE of the Week
Patti Geil, MS, RD, FADA, CDE

Category: Nutrition
Credits: .75